In vitro IgM and IgM rheumatoid factor production and response to remittive agents in rheumatoid arthritis

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.

Lupus·2019

Lupus: the new epidemic.

Lupus·2019

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Lupus·2019

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.

Lupus·2019

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Lupus·2017

Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL).

Lupus·2017

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Arthritis and rheumatism·2013

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Arthritis and rheumatism·2013

The association between cardiac arrhythmia and autoantibodies in systemic sclerosis.

Modern rheumatology·2026

Statin-induced myopathy is rare.

Danish medical journal·2026

Related Experiment Videos

In vitro IgM and IgM rheumatoid factor production and response to remittive agents in rheumatoid arthritis

Related Concept Videos

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.

Lupus: the new epidemic.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL).

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

The association between cardiac arrhythmia and autoantibodies in systemic sclerosis.

Statin-induced myopathy is rare.

Related Experiment Videos

In vitro IgM and IgM rheumatoid factor production and response to remittive agents in rheumatoid arthritis

Related Concept Videos

Related Articles